Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Weight Loss 1Pancreatic Neoplasms 1Hematologic Neoplasms 1Disease 1Cachexia 1Adenocarcinoma 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × bermekimab × Clear all
NCT01260545 2021-02-16

Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies

Janssen Research & Development, LLC

Phase 1 Completed
14 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03207724 2020-12-30

OnFX

Cedars-Sinai Medical Center

Phase 1 Completed
16 enrolled
Gastrointestinal

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡